Complication of enoxaparin(Alborz Daroo) compared with clexane(Aventis, Lupin) in patient whit Acute coronary syndrome

Phase 3

• Conditions: Acute coronary syndrome.; Acute ischaemic heart disease, unspecified

• Registration Number: IRCT2015090821979N2
• Lead Sponsor: Shahroud University of Medical Sciences and Health Services

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 240

Inclusion Criteria

all patients with ACS (STEMI, NON STEMI, unstable angina) shahroud referring to Imam Hossein hospital.
Exclusion criteria: the sensitivity of the lamina propria Anagza; those who have active bleeding; thrombocytopenia; previously received heparin.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Major bleeding. Timepoint: Until discharge from hospital. Method of measurement: Observation.;Minor bleeding. Timepoint: Until discharge from hospital. Method of measurement: Sheet urinary analysis.;Thrombocytopenia. Timepoint: Until discharge from hospital. Method of measurement: Patient test page.;PTT. Timepoint: Until discharge from hospital. Method of measurement: Patient test page.